RITROVA THERAPEUTICS INC.

NEW YORK, NY · Founded 2021 · CIK 0001841262 · Biotech · Private

Protein degradation therapeutics targeting disease-causing proteins

ritrovatherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$150K
1 Form D · Jan 2021
69 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$150,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2641Renova Therapeutics, Inc.—$167K
2642BIONANOTECH LLC——
2643GREFFEX, INC.—$155K
2644RITROVA THERAPEUTICS INC.—$150K
2645SYMMETRIC COMPUTING, INC.——
2646Ajaya Bio, Inc.—$150K
2647STEMSAVE INC—$150K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Cristina Maria AlberiniDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.